• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环糊精包合增强兰索拉唑的溶解和稳定性:制备、表征和分子模拟。

Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modeling.

机构信息

School of Pharmacy, Key Laboratory of Smart Drug Delivery of Ministry of Education and PLA, Fudan University, Shanghai, 201203, China.

出版信息

AAPS PharmSciTech. 2012 Dec;13(4):1222-9. doi: 10.1208/s12249-012-9842-z. Epub 2012 Sep 12.

DOI:10.1208/s12249-012-9842-z
PMID:22968546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3513431/
Abstract

In this study, lansoprazole (LSP)/cyclodextrin (CD) inclusion complexes were prepared using a fluid bed coating technique, with β-cyclodextrin (β-CD) and 2-hydroxypropyl-β-cyclodextrin (HPCD) as the host molecules, respectively, to simultaneously improve the dissolution and stability of LSP. The dissolution rate and stability of LSP was dramatically enhanced by inclusion complexation regardless of CD type. LSP/HPCD inclusion complex was more stable under illumination than LSP/β-CD inclusion complex. Differential scanning calorimetry and powder X-ray diffractometry proved the absence of crystallinity in both LSP/CD inclusion complexes. Fourier transform infrared spectroscopy together with molecular modeling indicated that the benzimidazole of LSP was included in the cavity of both CDs, while LSP was more deeply included in HPCD than β-CD. The enhanced photostability was due to the inclusion of the sulfinyl moiety into the HPCD cavity. CD inclusion complexation could improve the dissolution and stability of LSP.

摘要

在这项研究中,采用流化床包衣技术制备了兰索拉唑(LSP)/环糊精(CD)包合物,分别以β-环糊精(β-CD)和 2-羟丙基-β-环糊精(HPCD)为主体分子,以同时提高 LSP 的溶解和稳定性。无论 CD 类型如何,包合作用都能显著提高 LSP 的溶解速率和稳定性。与 LSP/β-CD 包合物相比,LSP/HPCD 包合物在光照下更稳定。差示扫描量热法和粉末 X 射线衍射法证明了两种 LSP/CD 包合物均无结晶度。傅里叶变换红外光谱和分子建模表明,LSP 的苯并咪唑部分被包含在两种 CD 的腔中,而 LSP 被 HPCD 包合的程度比β-CD 更深。光稳定性的提高是由于亚砜部分被包含在 HPCD 腔中。CD 包合作用可以提高 LSP 的溶解和稳定性。

相似文献

1
Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modeling.环糊精包合增强兰索拉唑的溶解和稳定性:制备、表征和分子模拟。
AAPS PharmSciTech. 2012 Dec;13(4):1222-9. doi: 10.1208/s12249-012-9842-z. Epub 2012 Sep 12.
2
Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.依托度酸与羟丙基-β-环糊精及辅助剂的包合作用:制剂表征与分子模拟研究
Mol Pharm. 2017 Apr 3;14(4):1231-1242. doi: 10.1021/acs.molpharmaceut.6b01115. Epub 2017 Mar 1.
3
Enhanced dissolution, stability and physicochemical characterization of ATRA/2-hydroxypropyl-β-cyclodextrin inclusion complex pellets prepared by fluid-bed coating technique.采用流化床包衣技术制备的维 A 酸/2-羟丙基-β-环糊精包合物微丸的增溶、稳定性及理化特性研究。
Pharm Dev Technol. 2013 Feb;18(1):130-6. doi: 10.3109/10837450.2011.653818. Epub 2012 Feb 5.
4
Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement.制备方法对尼莫地平与SBE-β-CD/HP-β-CD形成真性包合物及其溶出速率提高的影响。
AAPS PharmSciTech. 2015 Jun;16(3):704-15. doi: 10.1208/s12249-014-0257-x. Epub 2014 Dec 17.
5
Phase solubility behavior of hydrophilic polymer/cyclodextrin/lansoprazole ternary system studied at high polymer concentration and by response surface methodology.高聚合物浓度下亲水聚合物/环糊精/兰索拉唑三元体系的相溶解度行为及响应面法研究。
Pharm Dev Technol. 2012 Mar-Apr;17(2):236-41. doi: 10.3109/10837450.2010.531738. Epub 2010 Nov 10.
6
Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions.二氢青蒿素与羟丙基-β-环糊精和卵磷脂的三元体系:同时提高药物在水溶液中的溶解度和稳定性。
J Pharm Biomed Anal. 2013 Sep;83:141-8. doi: 10.1016/j.jpba.2013.05.001. Epub 2013 May 13.
7
[The study on the preparation and spectroscopic properties of hydroxypropyl-beta-cyclodextrin/glipizide inclusion complex].羟丙基-β-环糊精/格列吡嗪包合物的制备及光谱性质研究
Guang Pu Xue Yu Guang Pu Fen Xi. 2008 Mar;28(3):711-4.
8
Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state.环糊精包合对硝苯地平固态光稳定性的影响。
Int J Pharm. 2002 Aug 28;243(1-2):107-17. doi: 10.1016/s0378-5173(02)00263-6.
9
Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.通过形成西洛他唑包合物提高其口服生物利用度。
AAPS PharmSciTech. 2009;10(2):660-9. doi: 10.1208/s12249-009-9249-7. Epub 2009 May 21.
10
Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.羟丙基-β-环糊精与帕利哌酮的包合物:制备与表征
Curr Drug Discov Technol. 2014;11(4):271-8. doi: 10.2174/1570163812666150109103618.

引用本文的文献

1
Advancements in cyclodextrin-based controlled drug delivery: Insights into pharmacokinetic and pharmacodynamic profiles.基于环糊精的控释药物递送的进展:对药代动力学和药效学特征的见解。
Heliyon. 2024 Oct 30;10(21):e39917. doi: 10.1016/j.heliyon.2024.e39917. eCollection 2024 Nov 15.
2
Development of a Multifunctional Oral Dosage Form via Integration of Solid Dispersion Technology with a Black Seed Oil-Based Self-Nanoemulsifying Drug Delivery System.通过将固体分散技术与黑种草籽油基自纳米乳化药物递送系统相结合开发多功能口服剂型。
Biomedicines. 2023 Oct 9;11(10):2733. doi: 10.3390/biomedicines11102733.
3
Cyclodextrins and Their Derivatives as Drug Stability Modifiers.环糊精及其衍生物作为药物稳定性调节剂
Pharmaceuticals (Basel). 2023 Jul 28;16(8):1074. doi: 10.3390/ph16081074.
4
Combined Curcumin and Lansoprazole-Loaded Bioactive Solid Self-Nanoemulsifying Drug Delivery Systems (Bio-SSNEDDS).姜黄素与载兰索拉唑的生物活性固体自纳米乳化药物递送系统(Bio-SSNEDDS)联合使用
Pharmaceutics. 2021 Dec 21;14(1):2. doi: 10.3390/pharmaceutics14010002.
5
Improvement of Skin Penetration, Antipollutant Activity and Skin Hydration of 7,3',4'-Trihydroxyisoflavone Cyclodextrin Inclusion Complex.7,3',4'-三羟基异黄酮环糊精包合物的皮肤渗透性、抗污染活性及皮肤水合作用的改善
Pharmaceutics. 2019 Aug 8;11(8):399. doi: 10.3390/pharmaceutics11080399.
6
Photosensitive drugs: a review on their photoprotection by liposomes and cyclodextrins.光敏药物:脂质体和环糊精对其光保护作用的综述。
Drug Deliv. 2017 Dec;24(sup1):33-44. doi: 10.1080/10717544.2017.1386733.
7
Preparation and evaluation of enteric coated tablets of hot-melt extruded lansoprazole.热熔挤出兰索拉唑肠溶片的制备与评价
Drug Dev Ind Pharm. 2017 May;43(5):789-796. doi: 10.1080/03639045.2016.1220567. Epub 2016 Aug 21.
8
Co-solvation effect on the binding mode of the α-mangostin/β-cyclodextrin inclusion complex.共溶剂化对α-山竹黄酮/β-环糊精包合物结合模式的影响
Beilstein J Org Chem. 2015 Nov 25;11:2306-2317. doi: 10.3762/bjoc.11.251. eCollection 2015.
9
Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.含有冬凌草甲素/羟丙基-β-环糊精包合物的纳米混悬剂,通过改善溶解和渗透性提高口服生物利用度。
AAPS PharmSciTech. 2016 Apr;17(2):400-8. doi: 10.1208/s12249-015-0363-4. Epub 2015 Jul 18.
10
Novel patchouli alcohol ternary solid dispersion pellets prepared by poloxamers.泊洛沙姆制备的新型广藿香醇三元固体分散体微丸
Iran J Pharm Res. 2015 Winter;14(1):15-26.

本文引用的文献

1
Phase solubility behavior of hydrophilic polymer/cyclodextrin/lansoprazole ternary system studied at high polymer concentration and by response surface methodology.高聚合物浓度下亲水聚合物/环糊精/兰索拉唑三元体系的相溶解度行为及响应面法研究。
Pharm Dev Technol. 2012 Mar-Apr;17(2):236-41. doi: 10.3109/10837450.2010.531738. Epub 2010 Nov 10.
2
Influences of sodium carbonate on physicochemical properties of lansoprazole in designed multiple coating pellets.碳酸钠对设计的多层包衣微丸中兰索拉唑理化性质的影响。
AAPS PharmSciTech. 2010 Sep;11(3):1287-93. doi: 10.1208/s12249-010-9493-x. Epub 2010 Aug 18.
3
Piroxicam/2-hydroxypropyl-beta-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique.采用新型流化床包衣技术制备的吡罗昔康/2-羟丙基-β-环糊精包合物。
J Pharm Sci. 2009 Feb;98(2):665-75. doi: 10.1002/jps.21453.
4
Cyclodextrins as pharmaceutical solubilizers.环糊精作为药物增溶剂
Adv Drug Deliv Rev. 2007 Jul 30;59(7):645-66. doi: 10.1016/j.addr.2007.05.012. Epub 2007 May 29.
5
Interaction of omeprazole with a methylated derivative of beta-cyclodextrin: phase solubility, NMR spectroscopy and molecular simulation.奥美拉唑与β-环糊精甲基化衍生物的相互作用:相溶解度、核磁共振光谱和分子模拟
Pharm Res. 2007 Feb;24(2):377-89. doi: 10.1007/s11095-006-9161-8. Epub 2006 Dec 20.
6
Cyclodextrins and their pharmaceutical applications.环糊精及其药物应用。
Int J Pharm. 2007 Feb 1;329(1-2):1-11. doi: 10.1016/j.ijpharm.2006.10.044. Epub 2006 Nov 9.
7
Solid state interactions between the proton pump inhibitor omeprazole and various enteric coating polymers.质子泵抑制剂奥美拉唑与各种肠溶包衣聚合物之间的固态相互作用。
J Pharm Sci. 2006 Jun;95(6):1342-53. doi: 10.1002/jps.20450.
8
Degradation of lansoprazole and omeprazole in the aquatic environment.兰索拉唑和奥美拉唑在水生环境中的降解
Chemosphere. 2006 May;63(7):1087-93. doi: 10.1016/j.chemosphere.2005.09.003. Epub 2005 Nov 9.
9
Preparation of celecoxib-dimethyl-beta-cyclodextrin inclusion complex: characterization and in vitro permeation study.塞来昔布-二甲基-β-环糊精包合物的制备:表征及体外渗透研究
Eur J Med Chem. 2005 Jul;40(7):624-31. doi: 10.1016/j.ejmech.2005.03.001. Epub 2005 Apr 2.
10
Tablet formulation containing meloxicam and beta-cyclodextrin: mechanical characterization and bioavailability evaluation.含有美洛昔康和β-环糊精的片剂配方:机械特性及生物利用度评估。
AAPS PharmSciTech. 2004 Jul 27;5(4):e59. doi: 10.1208/pt050459.